David Russell has over 25 years’ experience within the pharmaceutical and biotech industry with a number of leading global companies including Roche, Actelion Pharmaceuticals, Celgene and Novogen. He has been responsible for building, leading and growing commercial teams resulting in multiple product launches in China, Australia and Asia in therapeutic areas covering hematology, oncology, immunology, cardiology and pulmonary medicine. Mr Russell was Head of Asia-Pacific and part of the global leadership team for Celgene Immunology from 2012 to 2014. Prior to this, he was founding general manager, legal representative and regional head of South East Asia for Celgene China. Mr Russell was also global brand leader for Swiss-based biopharmaceutical company, Actelion Pharmaceuticals where he was responsible for its expansion into Asia and China. He was also involved with ASX-listed global pharmaceutical company, Novogen in Australia and the US, where he worked on the dietary supplements, Promensil and Trinovin. He also held sales and marketing
management roles at Roche Australia. Mr Russell runs his own consultancy, focusing on commercial consulting and strategic marketing.